☆ 4.5 Letter

Clinical outcomes of early defibrotide discontinuation: a single-center case series

BONE MARROW TRANSPLANTATION (2023)

Related references

Note: Only part of the references are listed.
Article

Hottest topics in hematopoietic stem cell transplantation: a summary from the 8th International Transplant and Cellular Therapy Course

Edwin U. Suárez

Clinical Hematology International (2023)

Add to Collection
Article Hematology

Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant

Mary Nauffal et al.

Summary: Defibrotide has shown effectiveness in the treatment of VOD/SOS in patients, with high response rates and survival rates. Early diagnosis, prompt initiation of defibrotide, and minimizing dosing interruptions may be key factors in successful treatment of VOD/SOS.

BLOOD ADVANCES (2022)

Add to Collection
Letter Hematology

Time to Complete Response after Defibrotide Initiation in Hepatic Veno-Occlusive Disease: Is Less Actually More?

Patrick Hagen et al.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

Add to Collection
Article Hematology

Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day+100 survival following haematopoietic stem cell transplantation

Paul G. Richardson et al.

BRITISH JOURNAL OF HAEMATOLOGY (2017)

Add to Collection
Article Hematology

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Paul G. Richardson et al.

BLOOD (2016)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.